Super agers have genetic advantages against Alzheimer's risk

A new study finds that people over 80 who maintain sharp mental abilities, known as super agers, carry fewer copies of the main Alzheimer's risk gene and more of a protective variant. This genetic profile sets them apart even from other healthy seniors in the same age group. The research, led by Vanderbilt University Medical Center, highlights potential resilience factors against dementia.

People who remain mentally sharp well into their 80s possess a distinct genetic advantage that lowers their risk of Alzheimer's disease, according to a study published on January 16 in Alzheimer's & Dementia, the journal of the Alzheimer's Association. Super agers, defined as individuals aged 80 or older with memory and thinking skills comparable to those 20 to 30 years younger, showed significantly reduced presence of the APOE-ε4 gene variant, the strongest known genetic risk factor for late-onset Alzheimer's.

The analysis, drawing from the largest dataset of super agers to date, included genetic and clinical data from 18,080 participants across eight national aging cohorts via the Alzheimer's Disease Sequencing Project Phenotype Harmonization Consortium. Super agers were 68% less likely to carry APOE-ε4 compared to those aged 80 or older with Alzheimer's dementia, and 19% less likely than cognitively normal peers in the same age bracket. Memory performance determined super ager status, requiring scores above the average for adults aged 50 to 64.

Even more notably, super agers exhibited higher frequencies of the protective APOE-ε2 variant. They were 28% more likely to have this allele than cognitively normal adults over 80, and 103% more likely than those with Alzheimer's. The study population featured 1,412 non-Hispanic white super agers and 211 non-Hispanic Black super agers, alongside 8,829 individuals with Alzheimer's and 7,628 cognitively normal controls. Within the cohort, APOE-ε4 appeared in 43.9% of participants, higher than the global average of 13.7%.

"This was our most striking finding -- although all adults who reach the age of 80 without receiving a diagnosis of clinical dementia exhibit exceptional aging, our study suggests that the super-ager phenotype can be used to identify a particularly exceptional group of oldest-old adults with a reduced genetic risk for Alzheimer's disease," said lead researcher Leslie Gaynor, PhD, assistant professor of Medicine in the Division of Geriatric Medicine at Vanderbilt.

The findings, co-led by Alaina Durant and involving researchers from 15 universities, were supported by National Institutes of Health grants. Gaynor added that these results, the first linking APOE-ε2 to super ager status, could guide further exploration of dementia resilience mechanisms.

Articoli correlati

Illustration of scientists analyzing genetic data linking lower cholesterol to reduced dementia risk in a lab setting.
Immagine generata dall'IA

Genetic study links lower cholesterol to reduced dementia risk

Riportato dall'IA Immagine generata dall'IA Verificato

A large-scale genetic analysis of about 1.09 million people suggests that lifelong, genetically lower cholesterol—specifically non‑HDL cholesterol—is associated with substantially reduced dementia risk. Using Mendelian randomization to emulate the effects of cholesterol‑lowering drug targets such as those for statins (HMGCR) and ezetimibe (NPC1L1), the study found up to an approximately 80% lower risk per 1 mmol/L reduction for some targets. ([research-information.bris.ac.uk](https://research-information.bris.ac.uk/en/publications/cholesterollowering-drug-targets-reduce-risk-of-dementia-mendelia?utm_source=openai))

Researchers at University College London have found that up to 93 percent of Alzheimer's cases may be linked to variants of the APOE gene, far more than previously estimated. The analysis, published in npj Dementia, also indicates that nearly half of all dementia cases could depend on this gene. The discovery underscores APOE as a key target for future treatments.

Riportato dall'IA

Researchers have identified the gene ADAMTS2 as significantly more active in brain tissue from African Americans with Alzheimer's disease, marking a potential shared biological pathway across racial groups. This finding emerges from the largest study of its kind using brain samples from over 200 African American donors. The gene's prominence also appeared in a separate analysis of White individuals, suggesting broader implications for treatment.

New research finds that blood biomarkers associated with Alzheimer’s disease increase significantly faster in people with obesity than in those without. Drawing on five years of data from 407 volunteers, the study suggests that blood tests can detect obesity‑related changes earlier than brain scans, underscoring obesity as a major modifiable risk factor for Alzheimer’s.

Riportato dall'IA

A large genetic study has found that sharp rises in blood sugar after meals could significantly heighten the risk of Alzheimer’s disease. Researchers from the University of Liverpool analyzed data from over 350,000 UK Biobank participants, revealing a 69% increased risk linked to postprandial hyperglycemia. The effect appears independent of visible brain damage, pointing to subtler biological mechanisms.

Researchers at Washington University School of Medicine in St. Louis report that amyloid pathology in mouse models of Alzheimer’s disease disrupts circadian rhythms in microglia and astrocytes, altering the timing of hundreds of genes. Published October 23, 2025, in Nature Neuroscience, the study suggests that stabilizing these cell-specific rhythms could be explored as a treatment strategy.

Riportato dall'IA Verificato

Grandparents who provided childcare for their grandchildren scored higher on tests of memory and verbal fluency than those who did not, according to research published in the American Psychological Association’s journal *Psychology and Aging*. The study, based on long-running survey data in England, found the association held regardless of how often grandparents helped or what kinds of caregiving tasks they performed.

 

 

 

Questo sito web utilizza i cookie

Utilizziamo i cookie per l'analisi per migliorare il nostro sito. Leggi la nostra politica sulla privacy per ulteriori informazioni.
Rifiuta